GoodRx Holdings, Inc.·4

Feb 17, 5:26 PM ET

McGinnis Christopher A 4

Research Summary

AI-generated summary

Updated

GoodRx (GDRX) Insider Christopher McGinnis Receives RSUs; 52,799 Shares Withheld

What Happened

  • Insider Christopher A. McGinnis had 179,120 restricted stock units (RSUs) vest/convert into shares on Feb 15, 2026. Of those, 52,799 shares were withheld to cover tax liabilities at $2.18/share (totaling $115,102). The remaining net shares issued to McGinnis were approximately 126,321 shares (179,120 - 52,799). This was a vesting/settlement event (not an open-market buy or sale).

Key Details

  • Transaction date: 2026-02-15; Form 4 filed 2026-02-17 (appears timely).
  • Vesting/conversion: 179,120 RSUs converted to shares (reported as derivative exercise/ conversion).
  • Tax withholding: 52,799 shares withheld at $2.18/share for taxes, proceeds $115,102 (transaction code F).
  • Net shares received: ~126,321 shares (noting filing does not state total shares owned after the transaction).
  • Footnotes: F1 — each RSU equals a contingent right to one Class A common share. F2 — award vests 25% on Feb 15, 2026 with remaining 75% vesting in equal quarterly installments over 12 quarters.
  • Filing notes: No indication this was part of a 10b5-1 or other plan; filing was not flagged as late.

Context

  • This was a routine RSU vesting and cashless tax-withholding settlement — common for equity-compensation events. The derivative entries reflect RSUs converting into shares and shares withheld to satisfy tax obligations; such withholding is administrative and does not necessarily signal insider buying or selling intent.